GlassScriptPhysician profile
Randall Kevin Wolf
NPI 1851369417
$282,533.89
in general payments reported to CMS, 2019-2025
28 companies · $41K in 2025
The $41K reported for 2025 was more than what 96% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $43K · 2020: $13K · 2021: $17K · 2022: $109K · 2023: $37K · 2024: $22K · 2025: $41K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $89K · Travel and Lodging: $6,639 · Food and Beverage: $3,750.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $89,400.00 |
| Travel and Lodging | $6,639.36 |
| Food and Beverage | $3,750.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $257,121.07 | 2019-2025 | Epi-Sense Guided Coagulation System With Visitrax, Synergy Ablation System, Atriclip Laa Exclusion System |
| Scanlan International INC | $15,266.72 | 2019-2020 | |
| Dilon Technologies, INC. | $5,109.37 | 2022-2024 | Hemoblast Bellows |
| Boston Scientific Corporation | $1,169.39 | 2019-2025 | Ekosonic |
| Abbott Laboratories | $836.41 | 2019-2025 | Confirm Rx, Jot Dx |
| Baxter Healthcare | $447.56 | 2019-2025 | Preveleak |
| Medtronic Vascular, INC. | $344.91 | 2019-2020 | |
| Livanova USA, INC. | $320.24 | 2019-2020 | |
| Medinc of Texas | $255.53 | 2024-2025 | |
| Angiodynamics, INC. | $248.80 | 2022 | |
| Medtronic, INC. | $184.42 | 2021-2022 | |
| Silk Road Medical, INC. | $152.92 | 2023 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
| Ethicon INC. | $144.60 | 2021-2023 | |
| Biom'Up Sa | $134.35 | 2019 | |
| Getinge USA Sales, LLC | $117.64 | 2019 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $113.48 | 2019 | |
| Medical Device Business Services, INC. | $104.06 | 2019 | |
| Zimmer Biomet Holdings, INC. | $95.85 | 2019 | |
| Corcym INC | $92.08 | 2022 | |
| Edwards Lifesciences Corporation | $89.64 | 2022 | |
| Cardiva Medical, INC. | $48.25 | 2022 | |
| Amgen INC. | $31.20 | 2019 | |
| Bolton Medical INC | $29.65 | 2020 | |
| Heartflow, INC. | $25.82 | 2023 | Ffrct |
| Baylis Medical Technologies INC. | $18.13 | 2024 | |
| Cook Medical LLC | $16.14 | 2020 | |
| Janssen Pharmaceuticals, INC | $15.66 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$584,386.64 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Randall Wolf listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.